Latest Advanz Pharma News & Updates

See the latest news and media coverage for Advanz Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Advanz Pharma

Global specialty, hospital, and rare-disease pharmaceutical company

advanzpharma.com
Headquarters
London, United Kingdom
Company type
Public company
Number of employees
700–1,000

Last updated

Latest news about Advanz Pharma

In short: Advanz Pharma expanded its biosimilar portfolio through Alvotech partnerships while facing a major UK competition fine and regulatory hurdles in Europe.

Company announcements

  • Advanz Pharma

    ADVANZ PHARMA announces patent settlement for Eylea biosimilar

    Alvotech settles with Regeneron and Bayer, enabling marketing from January 2026 in UK and May 2026 in EEA and Switzerland.

  • Advanz Pharma

    Advanz Pharma expands portfolio via acquisition

    It acquires additional EMEA rights and global hospital medicine rights, strengthening global footprint and commitment to specialty medicines.

  • Advanz Pharma

    Advanz Pharma acquires Progynova, Cyclo-Progynova in EMEA, Ilomedin globally

    Progynova treats estrogen deficiency; Cyclo-Progynova regulates menstruation. Ilomedin addresses cardiovascular disorders including rare Thromboangiitis Obliterans. Deals expand specialty brands portfolio following prior Latin America and APAC acquisitions.

  • Advanz Pharma

    Advanz Pharma announces EC approval for Gobivaz

    The EC granted marketing authorizations for the biosimilar Gobivaz (golimumab) across the EEA for multiple indications and formats.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Advanz Pharma

Track Advanz Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Advanz Pharma competitors & trending companies

Browse news for competitors to Advanz Pharma and other trending companies.